Mitogen-actived protein kinase activation is an early event in melanoma progression

Clinical Cancer Research

Volumn 8, Issue 12, 2002, Pages 3728-3733

  Cohen, Cynthia ^a   Zavala Pompa, Angel ^a   Sequeira, Judy H ^a   Shoji, Mamoru ^a   Sexton, Deborah G ^a   Cotsonis, George ^a   Cerimele, Francesca ^a   Govindarajan, Baskaran ^a   Macaron, Nada ^a   Arbiser, Jack L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; THROMBOPLASTIN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STAINING;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INDUCING AGENTS; DISEASE PROGRESSION; ENZYME ACTIVATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MELANOMA; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; NEVUS, PIGMENTED; PHOSPHORYLATION; SKIN NEOPLASMS; THROMBOPLASTIN; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0036896253     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Sober, A. J., Lew, R. A., Koh, H. K., and Barnhill, R. L. Epidemiology of cutaneous melanoma. An update. Dermatol. Clin., 9: 617-629, 1991.
2. Sober, A. J., Fitzpatrick, T. B., Mihm, M. C., Wise, T. G., Pearson, B. J., Clark, W. H., and Kopf, A. W. Early recognition of cutaneous melanoma. JAMA, 242: 2795-2799, 1979.
3. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Wash. DC), 264: 436-440, 1994.
4. Chin, L., Merlino, G., and DePinho, R. A. Malignant melanoma: Modern black plague and genetic black box. Genes Dev., 12: 3467-3481, 1998.
5. Tsao, H., Zhang, X., Fowlkes, K., and Haluska, F. G. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. Cancer Res., 60: 1800-1804, 2000.
6. Ball, N. J., Yohn, J. J., Morelli, J. G., Norris, D. A., Golitz, L. E., and Hoeffler, J. P. Ras mutations in human melanoma: A marker of malignant progression. J. Investig. Dermatol., 102: 285-290, 1994.
7. Zhou, J. N., Ljungdahl, S., Shoshan, M. C., Swedenborg, J., and Linder, S. Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway. Mol. Carcinog., 21: 234-243, 1998.
8. Shoji, T., Park, H. Y., Jalbert, N., Bhawan, J., and Byers, H. R. In situ and in vitro expression of protein kinase C α in human melanocytes. Pigment Cell Res., 11: 18-23, 1998.
9. Hata, Y., Rook, S. L., and Aiello, L. P. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway. Diabetes, 48: 1145-1155, 1999.
10. Arbiser, J. L., Weiss, S. W., Arbiser, Z. K., Bravo, F., Govindajaran, B., Caceres-Rios, H., Cotsonis, G., Recavarren, S., Swerlick, R. A., and Cohen, C. Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: Implications for biologic behavior and response to therapy. J. Am. Acad. Dermatol., 44: 1-5, 2001.
11. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., and Gasparini, G. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst., 84: 1875-1887, 1992.
12. Duarte, I. G., Bufkin, B. L., Pennington, M. F., Gal, A. A., Cohen, C., Kosinski, A. S., Mansour, K. A., and Miller, J. I. Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer. J. Thorac. Cardiovasc. Surg., 115: 652-658, 1998.
13. Byers, H. R., Etoh, T., Doherty, J. R., Sober, A. J., Mihm, M. C., Jr. Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis. Am. J. Pathol., 139: 423-435, 1991.
14. LaMontagne, K. R., Jr., Moses, M. A., Wiederschain, D., Mahajan, S., Holden, J., Ghazizadeh, H., Frank, D. A., and Arbiser, J. L. Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells. Am. J. Pathol., 157: 1937-1945, 2000.
15. Arbiser, J. L. Melanoma. Lessons from metastases. Arch. Dermatol., 134: 1027-1028, 1998.
16. Fujita, M., Norris, D. A., Yagi, H., Walsh, P., Morelli, J. G., Weston, W. L., Terada, N., Bennion, S. D., Robinson, W., Lemon, M., Maxwell, I. H., and Yohn, J. J. Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivo. Melanoma Res., 9: 279-291, 1999.
17. Ball, N. J., Yohn, J. J., Morelli, J. G., Norris, D. A., Golitz, L. E., and Hoeffler, J. P. Ras mutations in human melanoma: A marker of malignant progression. J. Investig. Dermatol., 102: 285-290, 1994.
18. Wong, A. K., and Chin, L. An inducible melanoma model implicates a role for RAS in tumor maintenance and angiogenesis. Cancer Metastasis Rev., 19: 121-129, 2000.
19. Arbiser, J. L., Moses, M. A., Fernandez, C. A., Ghiso, N., Cao, Y., Klauber, N., Frank, D., Brownlee, M., Flynn, E., Parangi, S., Byers, H. R., and Folkman, J. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc. Natl. Acad. Sci. USA, 94: 861-866, 1997.
20. Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., Horner, J. W., Cordon-Cardo, C., Yancopoulos, G. D., and DePinho, R. A. Essential role for oncogenic Ras in tumour maintenance. Nature (Lond.), 400: 468-472, 1999.
21. Dotto, G. P., Moellmann, G., Ghosh, S., Edwards, M., and Halaban, R. Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J. Cell Biol., 109: 3115-3128, 1989.
22. Rak, J., Filmus, J., Finkenzeller, G., Grugel, S., Marme, D., and Kerbel, R. S. Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Rev., 14: 263-277, 1995.
23. Klafter, R., and Arbiser, J. L. Regulation of angiogenesis and tumorigenesis by signal transduction cascades: Lessons from benign and malignant endothelial tumors. J. Investig. Dermatol. Symp. Proc., 5: 79-82, 2000.
24. Hendrix, M. J., Seftor, E. A., Meltzer, P. S., Gardner, L. M., Hess, A. R., Kirschmann, D. A., Schatteman, G. C., and Seftor, R. E. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry. Proc. Natl. Acad. Sci. USA, 98: 8018-8023, 2001.
25. Hess, A. R., Seftor, E. A., Gardner, L. M., Carles-Kinch, K., Schneider, G. B., Seftor, R. E., Kinch, M. S., and Hendrix, M. J. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: Role of epithelial cell kinase (Eck/EphA2). Cancer Res., 61: 3250-3255, 2001.
26. Van Belle, P. A., Elenitsas, R., Satyamoorthy, K., Wolfe, J. T., Guerry, D., Schuchter, L., Van Belle, T. J., Albelda, S., Tahin, P., Herlyn, M., and Elder, D. E. Progression-related expression of β3 integrin in melanomas and nevi. Hum. Pathol., 30: 562-567, 1999.
27. Gitay-Goren, H., Halaban, R., and Neufeld, G. Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors. Biochem. Biophys. Res. Commun., 190: 702-708, 1993.
28. Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben Dor, A., Sampas, N., Dougherty, E., Wang, E., Marincola, F., Gooden, C., Lueders, J., Glatfelter, A., Pollock. P., Carpten, J., Gillanders, E., Leja, D., Dietrich, K., Beaudry, C., Berens, M., Alberts, D., and Sondak, V. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (Lond.), 406: 536-540, 2000.
29. Clark, E. A., Golub, T. R., Lander, E. S., and Hynes, R. O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature (Lond.), 406: 532-535, 2000.
30. Vink, J., Dekker, S. K., van Leeuwen, R. L., Vermeer, B. J., Bruijn, J. A., and Byers, H. R. Role of β 1 integrins in cell spreading and migration of human nevomelanocytes and dysplastic nevi cells on collagen type IV and laminin. Pigment Cell Res., 7: 339-347, 1994.
31. Polsky, D., Young, A. Z., Busam, K. J., and Alani, R. M. The transcriptional repressor of p16/Ink4a. Id1, is up-regulated in early melanomas. Cancer Res. 61: 6008-6011, 2001.
32. Alani, R. M., Young, A. Z., and Shifflett, C. B. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc. Natl. Acad. Sci. USA, 98: 7812-7816, 2001.
33. Zhu, J., Woods, D., McMahon, M., and Bishop, J. M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev., 12: 2997-3007, 1998.
34. Govindarajan, B., Klafter, R., Miller, M. S., Mansur, C., Mizesko, M., Bai, X., LaMontagne, K., Jr., and Arbiser, J. L. Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase. Mol. Med., 8: 1-8, 2002.
35. Mansour, S. J., Matten, W. T., Hermann, A. S., Candia, J. M., Rong, S., Fukasawa, K., Vande Woude, G. F., and Ahn, N. G. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science (Wash. DC), 265: 966-970, 1994.
36. Cowley, S., Paterson, H., Kemp, P., and Marshall, C. J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell, 77: 841-852, 1994.
37. Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B. A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W., Leung, S. Y., Yuen, S. T., Weber, B. L., Seigler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R., and Futreal, P. A. Mutations of the BRAF gene in human cancer. Nature (Lond.), 417: 949-954, 2002.
38. Contrino, J., Hair, G., Kreutzer, D. L., and Rickles, F. R. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease. Nat. Med., 2: 209-215, 1996.
39. Abe, K., Shoji, M., Chen, J., Bierhaus, A., Danave, I., Micko, C., Casper, K., Dillehay, D. L., Nawroth, P. P., and Rickles, F. R. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc. Natl. Acad. Sci. USA, 96: 8663-8668, 1999.
40. Medrano, E. E., Yang, F., Boissy, R., Farooqui, J., Shah, V., Matsumoto, K., Nordlund, J. J., and Park, H. Y. Terminal differentiation and senescence in the human melanocyte: Repression of tyrosine-phosphorylation of the extracellular signal-regulated kinase 2 selectively defines the two phenotypes. Mol. Biol. Cell. 5: 497-509, 1994.
41. Abriser, J. L., Petros, J., Klafter, R., Govindajaran, B., McLaughlin, E. R., Brown, L. F., Cohen, C., Moses, M., Kilroy, S., Arnold, R. S., Lambeth, J. D. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc. Natl. Acad. Sci. USA, 99: 715-720, 2002.
42. Lin, E. Y., Piepkorn, M., Garcia, R., Byrd, D., Tsou, R., and Isik, F. F. Angiogenesis and vascular growth factor receptor expression in malignant melanoma. Plast. Reconstr. Surg., 104: 1666-1674, 1999.
43. Erhard, H., Rietveld, F. J., van Altena, M. C., Brocker, E. B., Ruiter, D. J., and De Waal, R. M. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis. Melanoma Res., 7(Suppl. 2): S19-S26, 1997.
44. Vlaykova, T., Muhonen, T., Hahka-Kemppinen, M., Pyrhonen, S., and Jekunen, A. Vascularity and prognosis of metastatic melanoma. Int. J. Cancer, 74: 326-329, 1997.
45. Ilmonen, S., Kariniemi, A. L., Vlaykova, T., Muhonen, T., Pyrhonen, S., and Asko-Seljavaara, S. Prognostic value of tumour vascularity in primary melanoma. Melanoma Res., 9: 273-278, 1999.
46. Salven, P., Heikkila, P., and Joensuu, H. Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br. J. Cancer, 76: 930-934, 1997.
47. Carnochan, P., Briggs, J. C., Westbury, G., and Davies, A. J. The vascularity of cutaneous melanoma: A quantitative histological study of lesions 0.85-1.25 mm in thickness. Br. J. Cancer, 64: 102-107, 1991.
48. Busam, K. J., Berwick, M., Blessing, K., Fandrey, K., Kang, S., Karaoli, T., Fine, J., Cochran, A. J., White, W. L., and Rivers, J. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am. J. Pathol., 147: 1049-1056, 1995.
49. Barnhill, R. L., Piepkorn, M. W., Cochran, A. J., Flynn, E., Karaoli, T., and Folkman, J. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases. Arch. Dermatol., 134: 991-994, 1998.
50. Sebolt-Leopold, J. S., Dudley, D. T., Herrera, R., Van Becelaere, K., Wiland, A., Gowan, R. C., Tecle, H., Barrett, S. D., Bridges, A., Przybranowski, S., Leopold, W. R., and Saltiel, A. R. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med., 5: 810-816, 1999.